Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
RNH1
Introduction
Ribonuclease inhibitor is an enzyme that in humans is encoded by the RNH1 gene.[1]
Further reading
Further reading
- Zneimer SM, Crawford D, Schneider NR, Beutler B (1991). “Mapping of the human ribonuclease inhibitor gene (RNH) to chromosome 11p15 by in situ hybridization”. Genomics. 8 (1): 175–8. doi:10.1016/0888-7543(90)90242-M. PMID 2081593.
- Weremowicz S, Fox EA, Morton CC, Vallee BL (1991). “The placental ribonuclease inhibitor (RNH) gene is located on chromosome subband 11p15.5”. Genomics. 8 (4): 717–21. doi:10.1016/0888-7543(90)90260-2. PMID 2276743.
- Lee FS, Vallee BL (1989). “Binding of placental ribonuclease inhibitor to the active site of angiogenin”. Biochemistry. 28 (8): 3556–61. doi:10.1021/bi00434a061. PMID 2742853.
- Bond MD, Vallee BL (1989). “Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay”. Biochemistry. 27 (17): 6282–7. doi:10.1021/bi00417a013. PMID 3064806.
- Hofsteenge J, Kieffer B, Matthies R, et al. (1989). “Amino acid sequence of the ribonuclease inhibitor from porcine liver reveals the presence of leucine-rich repeats”. Biochemistry. 27 (23): 8537–44. doi:10.1021/bi00423a006. PMID 3219361.
- Lee FS, Fox EA, Zhou HM, et al. (1989). “Primary structure of human placental ribonuclease inhibitor”. Biochemistry. 27 (23): 8545–53. doi:10.1021/bi00423a007. PMID 3219362.
- Schneider R, Schneider-Scherzer E, Thurnher M, et al. (1989). “The primary structure of human ribonuclease/angiogenin inhibitor (RAI) discloses a novel highly diversified protein superfamily with a common repetitive module”. EMBO J. 7 (13): 4151–6. PMC 455125. PMID 3243277.
- Shapiro R, Vallee BL (1987). “Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin”. Proc. Natl. Acad. Sci. U.S.A. 84 (8): 2238–41. doi:10.1073/pnas.84.8.2238. PMC 304624. PMID 3470787.
- Kiyohara H, Menjo M (1984). “Ribonuclease and ribonuclease inhibitor in the human pancreas”. Gastroenterol. Jpn. 18 (5): 468–73. PMID 6653993.
- Nadano D, Yasuda T, Takeshita H, et al. (1994). “Purification and characterization of human brain ribonuclease inhibitor”. Arch. Biochem. Biophys. 312 (2): 421–8. doi:10.1006/abbi.1994.1328. PMID 8037455.
- Kobe B, Deisenhofer J (1994). “Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats”. Nature. 366 (6457): 751–6. doi:10.1038/366751a0. PMID 8264799.
- Papageorgiou AC, Shapiro R, Acharya KR (1997). “Molecular recognition of human angiogenin by placental ribonuclease inhibitor–an X-ray crystallographic study at 2.0 A resolution”. EMBO J. 16 (17): 5162–77. doi:10.1093/emboj/16.17.5162. PMC 1170149. PMID 9311977.
- Gaur D, Swaminathan S, Batra JK (2001). “Interaction of human pancreatic ribonuclease with human ribonuclease inhibitor. Generation of inhibitor-resistant cytotoxic variants”. J. Biol. Chem. 276 (27): 24978–84. doi:10.1074/jbc.M102440200. PMID 11342552.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). “Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Fu P, Chen J, Tian Y, et al. (2005). “Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitor”. Cancer Gene Ther. 12 (3): 268–75. doi:10.1038/sj.cgt.7700742. PMID 15592448.
- Iyer S, Holloway DE, Kumar K, et al. (2005). “Molecular recognition of human eosinophil-derived neurotoxin (RNase 2) by placental ribonuclease inhibitor”. J. Mol. Biol. 347 (3): 637–55. doi:10.1016/j.jmb.2005.01.035. PMID 15755456.
- Rual JF, Venkatesan K, Hao T, et al. (2005). “Towards a proteome-scale map of the human protein-protein interaction network”. Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
- Johnson RJ, McCoy JG, Bingman CA, et al. (2007). “Inhibition of Human Pancreatic Ribonuclease by the Human Ribonuclease Inhibitor Protein”. J. Mol. Biol. 368 (2): 434–49. doi:10.1016/j.jmb.2007.02.005. PMC 1993901. PMID 17350650.